India: Pharmaceutical

India: Pharmaceutical covers the sector overview of the pharmaceutical industry in India, the size and value of the generic market, drug master file (DMF) filings, US FDA approved manufacturing plants, and the sector performance in production and export. It also covers the new patent law, regulatory changes, R&D spending, generic opportunities, contract research and manufacturing (CRAM), market trends and outlook, plus the profile, comparative matrix and SWOT analysis of the industry leading players:

Dr.Reddy's Laboratories, Ranbaxy Laboratories, Cipla, Sun Pharmaceutical and Workhardt.

• 1. Industry Profile
  • 1.1 Sector Overview
  • 1.2 Sector Size and Value
    • 1.2.1 Generic Market
    • 1.2.2 Drug Master File (DMF) Filings
    • 1.2.3 US FDA Approved Manufacturing Plants
  • 1.3 Sector Performance
    • 1.3.1 Pharmaceutical Production
    • 1.3.2 Pharmaceutical Export
• 2. Market Trends and Outlook
  • 2.1 New Patent Law
  • 2.2 Regulatory Changes
  • 2.3 R&D Spending
  • 2.4 Exploiting Generic Opportunities
  • 2.5 Contract Research and Manufacturing (CRAM)
• 3. Leading Players and Comparative Matrix
  • 3.1 Leading Players
    • 3.1.1 Dr. Reddys Laboratories
    • 3.1.2 Ranbaxy Laboratories
    • 3.1.3 Cipla
    • 3.1.4 Sun Pharmaceutical
    • 3.1.5 Wockhardt
  • 3.2 Comparative Matrix
  • 3.3 SWOT Analysis